Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage

Abstract Background Cervical cancer (CC) is the third most common gynecological malignancy around the world. Cisplatin is an effective drug, but cisplatin resistance is a vital factor limiting the clinical usage of cisplatin. Enhancer of mRNA decapping protein 4 (EDC4) is a known regulator of mRNA d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Xiaoling Wu, Youwen Zhong, Qing Chen, Xin Zhang, Hua Zhang
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2020-10-01
Series:Hereditas
Assuntos:
Cervical Cancer
Cisplatin resistance
Enhancer of mRNA decapping protein 4 (EDC4)
Replication protein a (RPA)
DNA damage
Acceso en liña:http://link.springer.com/article/10.1186/s41065-020-00154-w
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares